The most widely prescribed GLP-1 RAs for weight management include: Semaglutide sold as Ozempic (diabetes) and Wegovy (weight loss), administered by weekly subcutaneous injection Tirzepatide sold as Mounjaro (diabetes) and Zepbound (weight loss), a dual GIP/GLP-1 agonist administered by weekly injection Liraglutide sold as Saxenda (weight loss) and Victoza (diabetes), administered by daily injection GLP-1 RAs were originally developed as diabetes treatments but have become widely used for obesity and weight management following large clinical trials showing substantial weight loss outcomes
Even mild dehydration can exacerbate symptoms of anxiety and impair cognitive function
How L-Carnitine aids fat metabolism involves its direct role in facilitating the breakdown of fats for fuel
(144) expounded on the modified GLP-1R agonists from the perspective of the patent
They can order the necessary bloodwork and other diagnostics to determine who will benefit from GLP-1s or other weight management approaches
Foretz, M., Guichard, C., Ferre, P